01
Jun
Jun
A Drug Is Credited With Slight Gains for Patients Who Have Lung Cancer
The drug Erbitux lengthened the survival of patients with advanced lung cancer by about five weeks, researchers have reported.
Relevant Links
Relevant Links
Leave a Reply
You must be logged in to post a comment.